ServicenavigationHauptnavigationTrailKarteikarten


Research unit
EU RFP
Project number
00.0604
Project title
THERAPEUTIC ANTIBODIES: Engineering human antibody derivatives, which specifically recognise and ablate new blood vessels, for the therapy of angiogenesis-related pathologies.

Texts for this project

 GermanFrenchItalianEnglish
Key words
-
-
-
Anzeigen
Alternative project number
-
-
-
Anzeigen
Research programs
-
-
-
Anzeigen
Short description
-
-
-
Anzeigen
Further information
-
-
-
Anzeigen
Partners and International Organizations
-
-
-
Anzeigen
Abstract
-
-
-
Anzeigen
References in databases
-
-
-
Anzeigen

Inserted texts


CategoryText
Key words
(English)
Angiogenesis; therapeutic antibodies; oncofetal fibronectin; tumot targeting;
Biotechnology; Environmental Protection; Innovation; Technology Transfer; Life Sciences; Medicine; Health; Waste Management
Alternative project number
(English)
EU project number: QLK3-CT-2001-01495
Research programs
(English)
EU-programme: 5. Frame Research Programme - 1.1.3 The 'cell factory'
Short description
(English)
See abstract
Further information
(English)
Full name of research-institution/enterprise:
ETH Zürich
Institut für Pharmazeutische Wissenschaften
ETH Hönggerberg, HCI G 396.4
Partners and International Organizations
(English)
Coordinator: Università degli Studi di Siena (I)
Abstract
(English)
Angiogenesis is a typical process, which underlies cancer, rheumatoid arthritis and the majority of blinding ocular disorders. The ability to selectively target and/or ablate new blood vessels will open diagnostic and therapeutic opportunities. Recently, our network has collaborated for the isolation of antibodies (Ab), which selectively recognise new-forming blood vessels. Two good-quality markers of angiogenesis have been identified. The corresponding high-affinity phage Ab, efficiently target tumoural neovasculature in vivo. We now propose to chemically modify anti- angiogenesis Ab and to test the biomedical potential of their conjugates. In particular, we will use radionuclides and fluorophores to investigate the potential of our labelled Ab for image diagnostics. We will also couple them to drugs, cytokines etc. and evaluate their therapeutic potential in suitable anima l models. We will continue to search for novel markers of angiogenesis.
References in databases
(English)
Swiss Database: Euro-DB of the
State Secretariat for Education and Research
Hallwylstrasse 4
CH-3003 Berne, Switzerland
Tel. +41 31 322 74 82
Swiss Project-Number: 00.0604